Lysogene announced new appointments to the board of directors. Dr. Mathieu Simon has been appointed by cooptation as an independent director. A graduate in internal medicine from the Faculty of Medicine of Paris VII, Dr. Simon is Senior Strategic Advisor at Messier Maris & Associés, an international investment bank. In addition, Karen Aiach, Founder and Chief Executive Officer of Lysogene, has been appointed Chair of the Board of Directors. Ms. Aiach succeeds Annette Clancy who held the post of Chair since 2015. Ms. Clancy will remain on the Board as an independent Director.